Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning
- PMID: 15240671
- DOI: 10.4049/jimmunol.173.2.845
Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning
Abstract
The coordinated expression of chemokines and receptors may be important in the directed migration of alloreactive T cells during graft-vs-host disease (GVHD). Recent work demonstrated in a murine model that transfer of CCR5-deficient (CCR5(-/-)) donor cells to nonconditioned haploidentical recipients resulted in reduced donor cell infiltration in liver and lymphoid tissues compared with transfer of CCR5(+/+) cells. To investigate the function of CCR5 during GVHD in conditioned transplant recipients, we transferred CCR5(-/-) or wild-type C57BL/6 (B6) T cells to lethally irradiated B6D2 recipients. Unexpectedly, we found an earlier time to onset and a worsening of GVHD using CCR5(-/-) T cells, which was associated with significant increases in the accumulation of alloreactive CD4(+) and CD8(+) T cells in liver and lung. Conversely, the transfer of CCR5(-/-) donor cells to nonirradiated recipients led to reduced infiltration of target organs, confirming previous studies and demonstrating that the role of CCR5 on donor T cells is dependent on conditioning of recipients. Expression of proinflammatory chemokines in target tissues was dependent on conditioning of recipients, such that CXCL10 and CXCL11 were most highly expressed in tissues of irradiated recipients during the first week post-transplant. CCR5(-/-) T cells were shown to have enhanced migration to CXCL10, and blocking this ligand in vivo improved survival in irradiated recipients receiving CCR5(-/-) T cells. Our data indicate that the effects of inhibiting CCR5/ligand interaction on donor T cells during GVHD differ depending on conditioning of recipients, a finding with potentially important clinical significance.
Similar articles
-
An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease.Exp Hematol. 2004 Mar;32(3):318-24. doi: 10.1016/j.exphem.2003.12.003. Exp Hematol. 2004. PMID: 15003318
-
Relationship between CCR5 and acute graft-versus-host disease in murine bone marrow transplantation.Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Oct;14(5):934-40. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006. PMID: 17096892
-
Alloreactive T Cells Display a Distinct Chemokine Profile in Response to Conditioning in Xenogeneic GVHD Models.Transplantation. 2019 Sep;103(9):1834-1843. doi: 10.1097/TP.0000000000002756. Transplantation. 2019. PMID: 31461746
-
C-C chemokine receptor 5 and acute graft-versus-host disease.Immun Inflamm Dis. 2022 Sep;10(9):e687. doi: 10.1002/iid3.687. Immun Inflamm Dis. 2022. PMID: 36039647 Free PMC article. Review.
-
Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.Blood Cells Mol Dis. 2008 Jan-Feb;40(1):48-54. doi: 10.1016/j.bcmd.2007.06.019. Epub 2007 Sep 10. Blood Cells Mol Dis. 2008. PMID: 17827036 Review.
Cited by
-
Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.JCI Insight. 2016 May 5;1(6):e86660. doi: 10.1172/jci.insight.86660. JCI Insight. 2016. PMID: 27195312 Free PMC article.
-
L-selectin and beta7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease.Blood. 2005 Dec 1;106(12):4009-15. doi: 10.1182/blood-2005-06-2339. Epub 2005 Aug 16. Blood. 2005. PMID: 16105972 Free PMC article.
-
The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review.Int J Mol Sci. 2019 Aug 9;20(16):3889. doi: 10.3390/ijms20163889. Int J Mol Sci. 2019. PMID: 31404983 Free PMC article.
-
Secondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: a shifting paradigm for T cell allo-activation.Biol Blood Marrow Transplant. 2010 May;16(5):598-611. doi: 10.1016/j.bbmt.2009.12.007. Epub 2010 Feb 1. Biol Blood Marrow Transplant. 2010. PMID: 20117226 Free PMC article.
-
Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease.Front Immunol. 2019 Mar 6;10:309. doi: 10.3389/fimmu.2019.00309. eCollection 2019. Front Immunol. 2019. PMID: 30906290 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials